Diagnosis and treatment specification for immunosuppressive therapy and rejection of liver transplantation in China (2019 edition)
10.3969/j.issn.1674-7445.2021.01.002
- VernacularTitle:中国肝移植免疫抑制治疗与排斥反应诊疗规范（2019版）
- Collective Name:Branch of Organ Transplantation of Chinese Medical Association
- Publication Type:Research Article
- Keywords:
Liver transplantation;
Immunosuppressive therapy;
Transplantation immunity;
Rejection
- From:
Organ Transplantation
2021;12(1):8-
- CountryChina
- Language:Chinese
-
Abstract:
The liver is an "immune-privileged organ". The incidence and severity of acute rejection after liver transplantation are significantly lower than those after the transplantation of other organs. However, postoperative rejection is still relatively common, and standardized immunosuppressive therapy is the key to guarantee the efficacy of transplantation. To further standardize the immunosuppressive therapy and diagnosis and treatment of rejection after liver transplantation, Branch of Organ Transplantation of Chinese Medical Association organized liver transplant experts to summarize the latest research progress at home and abroad, integrate international guidelines and clinical practice and formulate the "Diagnosis and treatment specification for immunosuppressive therapy and rejection of liver transplantation in China (2019 edition)" based upon the application principle and common regime of immunosuppressant, as well as diagnosis and treatment of various types of rejection after liver transplantation.
